Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration.
- DOI
- 10.1007/s10384-026-01401-9
- Published
- 2026 Jul 31
- Container
- Japanese journal of ophthalmology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10384-026-01401-9,
title = {Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration.},
author = {Hashiya N and Maruko I and Tanaka K and Honjo J and Miyara Y and Watanabe Y and Maruko R and Nakai A and Wakatsuki Y and Itagaki K and Maehira M and Terao N and Kataoka K and Okada AA and Koizumi H and Mukai R and Sekiryu T and Mori R and Japan AMD Research Consortium (JARC)},
year = {2026},
journal = {Japanese journal of ophthalmology},
doi = {10.1007/s10384-026-01401-9},
url = {https://doi.org/10.1007/s10384-026-01401-9}
}RIS
TY - JOUR TI - Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration. AU - Hashiya N AU - Maruko I AU - Tanaka K AU - Honjo J AU - Miyara Y AU - Watanabe Y AU - Maruko R AU - Nakai A AU - Wakatsuki Y AU - Itagaki K AU - Maehira M AU - Terao N AU - Kataoka K AU - Okada AA AU - Koizumi H AU - Mukai R AU - Sekiryu T AU - Mori R AU - Japan AMD Research Consortium (JARC) PY - 2026 JO - Japanese journal of ophthalmology DO - 10.1007/s10384-026-01401-9 UR - https://doi.org/10.1007/s10384-026-01401-9 ER -
APA
N, H., I, M., K, T., J, H., Y, M., Y, W., R, M., A, N., Y, W., K, I., M, M., N, T., K, K., AA, O., H, K., R, M., T, S., R, M., & (JARC), J. A. R. C. (2026). Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration.. Japanese journal of ophthalmology. https://doi.org/10.1007/s10384-026-01401-9
Source records
- pubmed · retrieved 2026-09-25T17:53:52.554Z